Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FH5FE
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,772
Award facts
- Contract value 100% obligated
- $27,772.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $27,772.00 to DMS Pharmaceutical Group Inc. for the supply of Nexplanon 68 mg implants, with an ultimate completion date of October 9, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order represents part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499,999,999 master agreement valid through November 2026 that enables the agency to procure comprehensive pharmaceutical products and medical supplies.
Nexplanon implants are subdermal contraceptive devices that support the medical supply needs of Department of Defense healthcare facilities. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively for contracts covering branded and generic prescription drugs, biologics, and medical consumables. The company's extensive portfolio of federal contract awards demonstrates its capability to deliver specialized pharmaceutical products, including oncology treatments, vaccines, and other critical medications to military health facilities nationwide.
Quick answers
Who was awarded contract SPE2DB25FH5FE?
SPE2DB25FH5FE was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FH5FE worth?
The government has obligated $27,772 on SPE2DB25FH5FE.
Is contract SPE2DB25FH5FE an order under another contract?
Yes. SPE2DB25FH5FE is a delivery order under SPE2DB22D9207, an indefinite delivery contract.
Was contract SPE2DB25FH5FE competed?
The extent of competition for SPE2DB25FH5FE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award